Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 31 of the 50 sources its claims cite were checked for support.

Strategies to Address Difficult Venous Access in Blood Sampling: A Comprehensive Meta-Analysis

Open access

Abstract

Background and Objectives: Difficult venous access (DVA) affects 10–26% of hospitalized patients and up to 60% in high-risk populations, leading to increased patient discomfort, delayed diagnosis, and substantial healthcare costs estimated at $4.7 billion annually in the United States. This meta-analysis aimed to systematically evaluate the effectiveness, safety, and implementation considerations of traditional and emerging strategies for obtaining blood samples in patients with DVA. Materials and Methods: We conducted a comprehensive systematic review and meta-analysis following PRISMA guidelines. We searched MEDLINE, Embase, CINAHL, and Cochrane databases from January 2016 to December 2023. Inclusion criteria encompassed randomized controlled trials, systematic reviews, and observational studies examining DVA interventions in adult and pediatric populations. Primary outcomes included first-attempt success rates, overall success rates, and complication rates. Statistical analysis used random-effects models with risk ratios and 95% confidence intervals. Results: Forty-seven studies involving 12,847 patients met the inclusion criteria. Technology-assisted approaches demonstrated superior outcomes compared to traditional techniques. Ultrasound guidance showed the highest effectiveness with a first-attempt success increase of 42% (RR 1.42, 95% CI 1.26–1.58, p < 0.001), followed by near-infrared visualization with a 28% increase (RR 1.28, 95% CI 1.14–1.42, p < 0.001). Population-specific approaches yielded significant benefits, including the use of scalp veins for infants and external jugular approaches for extreme DVA cases. Cost-effectiveness analysis revealed that ultrasound guidance achieved break-even within 8–14 months in high-volume centers. Conclusions: A systematic, stepwise approach integrating appropriate technology and techniques significantly improves success rates while reducing patient discomfort and healthcare costs. Healthcare institutions should implement comprehensive DVA protocols with adequate training, equipment access, and quality monitoring. The proposed algorithm achieved a 93% overall success rate in validation studies, representing a substantial improvement over traditional approaches.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis of 47 studies (12,847 patients) found that technology-assisted and population-specific strategies improve difficult venous access (DVA) blood sampling, with ultrasound guidance showing the largest first-attempt benefit (RR 1.42) and a proposed stepwise algorithm achieving 93% overall success in validation. It also reports cost savings and implementation factors such as champion-based adoption and simulation training.

Key findings

  • Ultrasound-guided venipuncture improved first-attempt success (RR 1.42, 95% CI 1.26–1.58, p < 0.001; NNT 3.2), overall success (RR 1.54, 95% CI 1.40–1.70, p < 0.001; NNT 2.1), reduced complications (RR 0.41, 95% CI 0.33–0.52, p < 0.001), reduced pain by 2.4 VAS points (95% CI 1.8–3.0), and reduced procedure time by 2.2 min (95% CI 1.4–3.0).
  • Near-infrared visualization improved first-attempt success (RR 1.28, 95% CI 1.14–1.42, p < 0.001; NNT 4.7), reduced procedure time by 1.8 min (95% CI 0.8–2.8), and showed larger effects in pediatric patients (RR 1.45) than adults (RR 1.18), with benefit in obese patients (RR 1.34) but limited effectiveness with dark skin pigmentation or veins >4 mm deep.
  • Population-specific approaches: infant scalp venipuncture had 89% vs 62% first-attempt success (RR 1.43, 95% CI 1.28–1.60, p < 0.001) and lower FLACC pain scores (mean difference −2.1, 95% CI −2.8 to −1.4); external jugular access had 76% first-attempt success (95% CI 71–81%) and 94% overall success (95% CI 91–97%), with 4.2% minor and 0.1% serious complications; forearm venipuncture in elderly patients had 68% vs 51% success (RR 1.33, 95% CI 1.18–1.50).
  • Economic and implementation findings: traditional DVA draws averaged $47 per successful draw vs $31–$38 for technology-assisted approaches; a 300-bed hospital could save $285,000–$420,000 annually, with implementation costs of $25,000–$75,000 recovered in 6–18 months. Champion-based implementation had higher adoption (OR 3.2, 95% CI 2.1–4.8), simulation training achieved 87% skill retention at six months vs 54% for didactic training, and the validated stepwise algorithm achieved 93% overall success, reduced mean attempts from 3.2 to 1.4, reduced complications by 67%, and saved 4.3 min per DVA patient.

Methods

  • PRISMA-guided systematic review and meta-analysis searching MEDLINE, Embase, CINAHL, and Cochrane Central Register of Controlled Trials, plus manual reference screening and trial registries; inclusion covered randomized controlled trials, systematic reviews, and prospective observational studies published from January 2016 to June 2025 (abstract states January 2016 to December 2023) examining DVA blood sampling strategies in adult and pediatric patients.
  • Two independent reviewers screened titles/abstracts and full texts, extracted data with a standardized form, and resolved disagreements by discussion or a third reviewer; quality was assessed with Cochrane RoB 2, Newcastle–Ottawa Scale, and AMSTAR 2.
  • Random-effects meta-analyses were performed in Review Manager 5.4 and R, with heterogeneity assessed by I² and subgroup/sensitivity analyses; economic analysis incorporated direct and indirect costs converted to 2023 US dollars. The review included 47 studies, with 41 providing data for quantitative meta-analysis.

Limitations

  • The paper states that the meta-analysis could not quantitatively assess learning curves or how success varies by operator experience, and that long-term outcomes such as repeated access success, complication recurrence, and impact on patient throughput and staff efficiency were limited.
  • The paper also states that inability to blind interventions in many studies introduced potential performance bias, and that more detailed long-term analysis is needed to fully capture return on investment.
  • Evident from the text: the search period is inconsistent between the abstract (January 2016–December 2023) and methods (January 2016–June 2025); quality assessment describes 28 RCTs and 12 prospective cohort studies but does not report quality results for the 5 systematic reviews and 2 quasi-randomized trials included among the 47 studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/medicina62030604

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flow diagram of study selection process.
Figure 1 PRISMA flow diagram of study selection process.CC BY · PubMed Central
Figure 2 Risk of bias assessment results for included studies.
Figure 2 Risk of bias assessment results for included studies.CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 19 Not valid · 11 Not checked · 48 Own results and interpretations

52 more claims · 9 with their cited sources checked

Create a free account to see all 83 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 15
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Cho, C., Koser, B.W., and Das, J.M. (2025, December 16). Scalp Vein Catheterization, StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK565911/.

Metadata

Authors
Mussa, B., Passarella, G., Marchese, M., & Defrancisco, B.
Affiliations
University of Turin (IT)
Corresponding author
Mussa, Baudolino
Venue
Medicina
Publisher
MDPI AG
Published
2026-03-23
Volume
62
Issue
3
Pages
604
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W7140109477
Cited by
2
References
30
Citations by year
2026: 2
FWCI
4.32
Type
journal article
Language
en
Open access
Locations
  • Medicina (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Central Venous Catheters and Hemodialysis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
difficult venous access, blood sampling, ultrasound-guided venipuncture, first-attempt success rate, external jugular vein, cost-effectiveness, patient discomfort
MeSH terms
Blood Specimen Collection, Humans, Phlebotomy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies to Address Difficult Venous Access in Blood Sampling: A Comprehensive Meta-Analysis. https://app.cochat.ai/papers/10.3390/medicina62030604
The paper
Mussa, B., Passarella, G., Marchese, M., & Defrancisco, B. (2026). Strategies to Address Difficult Venous Access in Blood Sampling: A Comprehensive Meta-Analysis. Medicina. https://doi.org/10.3390/medicina62030604

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.